NF2 and meningioma: Among them, loss of 1p is most frequently observed7, 25, 28, 29 and reported as an independent marker for adverse clinical outcomes,7, 24, 30 so 1p loss is estimated as the first CNV occurring after 22q loss in high‐grade meningioma with NF2 gene alteration.31, 32